PATENT CLAIM ANALYSIS

Application Number: 16135620
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-05
Patent Classification: ["424", "613000"]

Abstract:
The use of gaseous oxygen for the production of a therapeutic gas for inhalation by a patient who has been identified as a person with a mitochondrial disorder or a coenzyme Q10 deficiency, for the treatment of mitochondrial disorders or Q10 deficiencies is disclosed. For the first time a non-invasive method is disclosed, upon what the body's own level of Q10 can be raised significantly without further interventions.

Claim (Index 13):
The method according to  claim 1 , wherein inhalation of the gas is performed in at least two time sessions, one of the time sessions being a hyperoxia session in which the concentration of the oxygen in the therapeutic gas is from about 38 Vol-% to about 55 Vol-%.

Metadata:
- Claim Count in Document: 22.0
- Percentile: 97.0
- Lexical Diversity: 1.40385
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13504821', '12777902', '14171419', '15862856', '15536603']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7039573743281675
- 35 USC 102 Novelty (BERT): 0.537680004213961
- Combined Prediction Score: 0.6873296373167469
- Mean Citation Score: 183.40735
- Max Citation Score: 373.6578
- Similarity Product: 233.4400892552376

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test